June M. Lau

Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation.

Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation.

Journal: Annals of hematology
Published: March 06, 2025

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong.

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong.

Journal: Therapeutic advances in hematology
Published: January 06, 2025

Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.

Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.

Journal: Annals of hematology
Published: October 23, 2021

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Journal: Cancer medicine
Published: October 10, 2019

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Journal: Cancer
Published: May 16, 2019

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.

Journal: American journal of hematology
Published: February 01, 2019

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Journal: Cancer
Published: January 08, 2019

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Journal: Cancer
Published: December 27, 2017

Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity.

Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity.

Journal: Annals of hematology
Published: November 20, 2016

Occupational risk factors for nasopharyngeal carcinoma in Hong Kong Chinese: a case-referent study.

Occupational risk factors for nasopharyngeal carcinoma in Hong Kong Chinese: a case-referent study.

Journal: International archives of occupational and environmental health
Published: May 24, 2016

Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis.

Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 21, 2015

Tobacco smoking, family history, and the risk of nasopharyngeal carcinoma: a case-referent study in Hong Kong Chinese.

Tobacco smoking, family history, and the risk of nasopharyngeal carcinoma: a case-referent study in Hong Kong Chinese.

Journal: Cancer causes & control : CCC
Published: July 21, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026